Bacterial extract for the prevention of recurrent urinary tract infections in pregnant women: A pilot study

International Journal of Immunotherapy

Volumn 19, Issue 1, 2003, Pages 25-31

  Baertschi, R ^a   Balmer, J A ^a   Eduah, S B ^a   Liechti, A ^a   Lurie, D ^a   Schams, H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOSTIMULATING AGENT; OM 8930; UNCLASSIFIED DRUG; URO VAXOM;

ACUTE DISEASE; ADULT; ANTIBIOTIC THERAPY; APGAR SCORE; ARTICLE; CHILDBIRTH; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIVERY; DRUG CAPSULE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; EMBRYOTOXICITY; FEMALE; HEARTBURN; HUMAN; IMMUNOREACTIVITY; INCIDENCE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NEWBORN; PATIENT MONITORING; PILOT STUDY; PREGNANCY; RECURRENT INFECTION; STATISTICAL SIGNIFICANCE; TERATOGENICITY; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 0346025741     PISSN: 02559625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Foxman B. Epidemiology of urinary tract infections: Incidence, morbidity and economic costs. Am. J. Med., 113 (Suppl. 1A), 5s, 2002.
2. Engel J.D., Schaeffer A.J. Evaluation of and antimicrobial therapy for recurrent urinary tract infections in women. Urol. Clin. North Am., 25, 685, 1998.
3. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. N. Engl. J. Med., 329, 1328, 1993.
4. Romero R., Oyarzun E., Mazor M., et al. Meta-analysis of the relationship between symptomatic bacteriuria and pre-term delivery/low birth weight. Obstet Gynecol., 73, 576, 1989.
5. Wang E., Smaill F. Infection in pregnancy. In: Chalmers I., Enkin M., Keirse M.J. (Eds.). "Effective Care in Pregnancy and Childbirth". Oxford University Press, Oxford, 1990, pp. 535-538.
6. McFayden I.R,. Campbell-Brown M., Stephenson M., et al. Single-dose treatment of bacteriuria in pregnancy. Eur. J. Urol., 13 (Suppl. 1), 22, 1987.
7. Masterton R.G., Evans D.C., Strike P.W. Single-dose amoxycillin in the treatment of bacteriuria in pregnancy and puerperium - a controlled clinical trial. Br. J. Obstet. Gynaecol., 92, 498, 1985.
8. Chauveau D., Jungers P., Grunfeld J.P. Urinary tract infections during pregnancy. Diagnosis, course, prognosis and treatment. Rev. Prat., 47, 1933, 1997.
9. Hall D.R., Theron G.B., van der Horst W. Significance and treatment of asymptomatic bacteriuria during pregnancy. Int. J. Gynaecol. Obstet., 57, 179, 1997.
10. MacLean A.B. Urinary tract infection in pregnancy. Br. J. Urol., 80 (Suppl. 1), 10, 1997.
11. Patterson T.F., Andriole V.T. Detection, significance, and therapy of bacteriuria in pregnancy. Update in the managed health care era. Infect. Dis. Clin. North Am., 11, 593, 1997.
12. Bosch A., Benedi V.J., Pares R., et al. Enhancement of the humoral immune response and resistance to bacterial infection in mice by the oral administration of a bacterial immunomodulator (OM-89). Immunopharmacol. Immunotoxicol., 10, 333, 1988.
13. Huber M., Baier W., Serr A., et al. Immunogenicity of an E. coli extract after oral or intraperitoneal administration: Induction of antibodies against pathogenic bacterial strains. Int. J. Immunopharmacol., 22, 57, 2000.
14. Pham Van T., Kreis B., Corradin-Betz S., et al. Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): In vitro studies. J. Biol. Resp. Modifiers, 9, 231, 1990.
15. Riedasch G., Kälbe T, Möhring K. Vaccination therapy of recurrent urinary tract infections of girls with Uro-Vaxom. Zschr. Antimikrob. Antineopl. Chemother., Suppl. 1, A257, 1989.
16. Wybran J., Libin M., Schandene L. Enhancement of cytokine production and natural killer activity by an Escherichia coli extract. Onkologie, 12 (Suppl. 3), 22, 1989.
17. Schmidhammer S., Ramoner R., Hoelth L., et al. An Escherichia coli-based oral vaccine against respiratory tract infections potently activates human dendritic cells. Urol., 60, 521, 2002.
18. Schneider H.J. Immunstimulation: Neuer Therapieansatz bei rezidivierenden Harnwegsinfekten. Der Allgemeinarzt, 12, 626, 1990.
19. James-Ellison M.Y., Roberts R., Verrier-Jones K. et al. Mucosal immunity in the urinary tract: Changes in slgA, FSC and total lgA with age and in urinary tract infection. Clin Nephrol., 48, 69, 1997.
20. Riedasch G., Möhring K. Immuntherapeutikum beugt Rezidivien vor. Urolog. Nephrolog., 10, 345, 1998.
21. Frey C., Obolensky W., Wyss H. Treatment of recurrent urinary tract infections: Efficacy of an orally administered biological response modifier. Urol Int., 41, 444, 1986.
22. Hachen H.J. Oral immunotherapy in paraplegic patients with chronic urinary tract infections: A double-blind, placebo-controlled trial, J. Urol., 143, 759, 1990.
23. Lettgen B. Prevention of recurrent urinary tract infections in female children. OM-89 immunotherapy compared with nitrofurantoin prophylaxis in a randomized pilot study. Curr. Therap. Res., 57, 463, 1996.
24. Magasi P., Panovisc J., Illes A., et al. Uro-Vaxom® and the management of recurrent urinary tract infection in adults: A randomized multicenter double-blind trial. Eur. Urol., 26, 137, 1994.
25. Rugendorff E.W. Immunological therapy of recurrent urinary tract infections with immunoactive E. coli fractions in women. Int. Urogynecol. J., 3, 179, 1992.
26. Schulmann C.C., Corbusier A., Michiels H., et al. Oral immunotherapy of recurrent urinary tract infections: A double-blind placebo-controlled study of OM-8930 in recurrent urinary tract infections conducted in Belgium and in the Federal Republic of Germany J. Urol., 150, 917, 1993.
27. Tammen H., Frey C. Treatment of recurrent urinary tract infections with Uro-Vaxom: Open multicenter study with 521 patients. Urologe (B), 28, 294, 1988.
28. Tammen H. and the German Urinary Tract Infection Study Group. Immunobiotherapy with Uro-Vaxom in recurrent urinary tract infection. Br. J. Urol., 65, 6, 1990.
29. Bauer H.W., Volker W.R., Lauener P.A., et al. Prevention of recurrent urinary tract infections with immunoactive E. coli fractions. A metaanalysis of five placebo-controlled double-blind studies. Int. J. Antimicrobial. Agents, 19, 451, 2002.